Assignee
HUMABS BIOMED SA
CH·19 granted patents·12 pending applications·27 citations·filing 2013–2025
Top patents by PatentIndex Score
31 records- 0198US11390664B2Antibodies that potently neutralize hepatitis B virus and uses thereofHUMABS BIOMED SA·Filed 2020·Granted Jul 19, 2022·5 cites·26 claims
- 0293US10683344B2Antibodies that potently neutralize hepatitis B virus and uses thereofHUMABS BIOMED SA·Filed 2016·Granted Jun 16, 2020·6 cites·18 claims
- 0386US10329342B2Antibodies that potently neutralize RSV and uses thereofHUMABS BIOMED SA·Filed 2018·Granted Jun 25, 2019·3 cites·20 claims
- 0485US11117954B2Antibodies specifically binding to zika virus epitopes and uses thereofHUMABS BIOMED SA·Filed 2017·Granted Sep 14, 2021·2 cites·31 claims
- 0585US10072071B2Antibodies that neutralize RSV, MPV and PVM and uses thereofHUMABS BIOMED SA·Filed 2016·Granted Sep 11, 2018·2 cites·31 claims
- 0685US10047145B2Antibodies that potently neutralize RSV and uses thereofHUMABS BIOMED SA·Filed 2014·Granted Aug 14, 2018·5 cites·33 claims
- 0784US12304946B2Antibodies that neutralize hepatitis B virus and uses thereofHUMABS BIOMED SA·Filed 2019·Granted May 20, 2025·1 cites·28 claims
- 0883US10759847B2Antibodies that potently neutralize RSV and uses thereofHUMABS BIOMED SA·Filed 2019·Granted Sep 1, 2020·1 cites·19 claims
- 0982US9498531B2Antibodies that neutralize RSV, MPV and PVM and uses thereofHUMABS BIOMED SA·Filed 2013·Granted Nov 22, 2016·2 cites·26 claims
- 1078US12037381B2Antibodies that potently neutralize hepatitis B virus and uses thereofHUMABS BIOMED SA·Filed 2022·Granted Jul 16, 2024·0 cites·20 claims
- 1177US2025353900A1Antibodies that neutralize hepatitis b virus and uses thereofHUMABS BIOMED SA·Filed 2025·Application pending·0 cites
- 1277US2024050565A1Antibodies that potently neutralize rabies virus and other lyssaviruses and uses thereofHUMABS BIOMED SA·Filed 2023·Application pending·0 cites
- 1376US2024254207A1Multispecific antibodies specifically binding to zika virus epitopes and uses thereofHUMABS BIOMED SA·Filed 2024·Application pending·0 cites
- 1473US11370829B2Antibodies that potently neutralize RSV and uses thereofHUMABS BIOMED SA·Filed 2020·Granted Jun 28, 2022·0 cites·20 claims
- 1572US11421020B2Antibodies that neutralize RSV, MPV and PVM and uses thereofHUMABS BIOMED SA·Filed 2020·Granted Aug 23, 2022·0 cites·20 claims
- 1671US11912757B2Antibodies specifically binding to Zika virus epitopes and uses thereofHUMABS BIOMED SA·Filed 2021·Granted Feb 27, 2024·0 cites·32 claims
- 1767US11730813B2Broadly neutralizing antibodies directed against the rabies virus glycoprotein and uses thereofHUMABS BIOMED SA·Filed 2020·Granted Aug 22, 2023·0 cites·34 claims
- 1867US11723977B2Broadly neutralizing antibodies directed against the rabies virus glycoprotein and uses thereofHUMABS BIOMED SA·Filed 2020·Granted Aug 15, 2023·0 cites·20 claims
- 1966US2019153073A1Antibodies that neutralize rsv, mpv and pvm and uses thereofHUMABS BIOMED SA·Filed 2018·Application pending·0 cites
- 2061US2026028391A1Broadly neutralizing antibodies against rsv and mpv paramyxovirusesHUMABS BIOMED SA·Filed 2023·Application pending·0 cites
- 2160US11926658B2Multispecific antibodies specifically binding to Zika virus epitopesHUMABS BIOMED SA·Filed 2018·Granted Mar 12, 2024·0 cites·21 claims
- 2260US10703801B2Antibodies that potently neutralize rabies virus and other lyssaviruses and uses thereofHUMABS BIOMED SA·Filed 2015·Granted Jul 7, 2020·0 cites·16 claims
- 2360US2024101648A1Antibodies against respiratory syncytial virus, human metapneumovirus and pneumonia virus of mice and methods of using the sameHUMABS BIOMED SA·Filed 2022·Application pending·0 cites
- 2458US10335484B2Methods of generating robust passive and active immune responsesHUMABS BIOMED SA·Filed 2014·Granted Jul 2, 2019·0 cites·13 claims
- 2556US2026021173A1Antibodies and methods for treatment of lyssavirus infectionHUMABS BIOMED SA·Filed 2025·Application pending·0 cites
- 2655US2022064267A1Antibodies and methods for treatment of lyssavirus infectionHUMABS BIOMED SA·Filed 2019·Application pending·0 cites
- 2754US2019336597A1Methods of generating robust passive and active immune responsesHUMABS BIOMED SA·Filed 2019·Application pending·0 cites
- 2853US2024034772A1Antibodies binding to f-protein of metapneumovirus and uses thereofHUMABS BIOMED SA·Filed 2021·Application pending·0 cites
- 2948US2023084102A1Antibodies binding to plasmodium circumsporozoite protein and uses thereofHUMABS BIOMED SA·Filed 2020·Application pending·0 cites
- 3045US2022226470A1Antibodies and methods for treatment of influenza a infectionHUMABS BIOMED SA·Filed 2020·Application pending·0 cites
- 3142US12297258B2Antibodies against Campylobacter speciesHUMABS BIOMED SA·Filed 2019·Granted May 13, 2025·0 cites·38 claims
Join the waitlist — get patent alerts
Get an alert when HUMABS BIOMED SA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →